Kazushi Yamamoto
Takamatsu, 7610301, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Oral Administration of Lipopolysaccharide Enhances Insulin Signaling-Related Factors in the KK/Ay Mouse Model of Type 2 Diabetes Mellitus.
Journal: International journal of molecular sciences
Published: January 31, 2023
Oral Administration of Lipopolysaccharide Prevents Cognitive Impairment in Streptozotocin-induced Diabetic Mice in a Blood Glucose-independent Manner.
Journal: Anticancer research
Published: May 21, 2021
Prevention of streptozotocin‑induced Neuro‑2a cell death by C8‑B4 microglia transformed with repetitive low‑dose lipopolysaccharide.
Journal: Molecular medicine reports
Published: February 02, 2021
Prevention of Diabetes-Associated Cognitive Dysfunction Through Oral Administration of Lipopolysaccharide Derived From Pantoea agglomerans.
Journal: Frontiers in immunology
Published: January 06, 2021
Virucidal activity of oral care products against SARS-CoV-2 in vitro.
Journal: Journal of oral and maxillofacial surgery, medicine, and pathology
Published: November 27, 2020
A Novel Anti-inflammatory Phenotype Transformed by Repetitive Low-dose Lipopolysaccharide in Primary Peritoneal Tissue-resident Macrophages.
Journal: Anticancer research
Published: June 04, 2020
A unique hybrid characteristic having both pro- and anti-inflammatory phenotype transformed by repetitive low-dose lipopolysaccharide in C8-B4 microglia.
Journal: Scientific reports
Published: March 25, 2020
Simultaneous Intake of Euglena gracilis and Vegetables Exerts Synergistic Anti-Obesity and Anti-Inflammatory Effects by Modulating the Gut Microbiota in Diet-Induced Obese Mice.
Journal: Nutrients
Published: December 24, 2018
Last Updated: 09/26/2026